A double-blind placebo-controlled trial of UVA-1 in the treatment of dyshidrotic eczema

Clinical and Experimental Dermatology

Volumn 28, Issue 6, 2003, Pages 584-587

  Polderman, M C A ^a   Govaert, J C M ^a   Le Cessie, S ^a   Pavel, S ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DESQUAMATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; ERYTHEMA; HAND ECZEMA; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; PHOTOTHERAPY; POMPHOLYX; PRIORITY JOURNAL; PRURITUS; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SAFETY; SCORING SYSTEM; SKIN; TREATMENT OUTCOME; ULTRAVIOLET A RADIATION; VISUAL ANALOG SCALE;

ADOLESCENT; ADULT; AGED; DOUBLE-BLIND METHOD; ECZEMA, DYSHIDROTIC; HAND DERMATOSES; HUMANS; MIDDLE AGED; TREATMENT OUTCOME; ULTRAVIOLET THERAPY;

EID: 0242407047     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.2003.01378.x     Document Type: Article

References (16)

1. Grattan CE, Carmichael AJ, Shuttleworth GJ, Foulds IS. Comparison of topical PUVA with UVA for chronic vesicular hand eczema. Acta Derm Venereol 1991; 71: 118-22.
2. LeVine MJ, Parrish JA, Fitzpatrick TB. Oral methoxsalen photochemotherapy (PUVA) of dyshidrotic eczema. Acta Derm Venereol 1981; 61: 570-1.
3. Schempp CM, Muller H, Czech W et al. Treatment of chronic palmoplantar eczema with local bath-PUVA therapy. J Am Acad Dermatol 1997; 36: 733-7.
4. Schmidt T, Abeck D, Boeck K et al. UVA1 irradiation is effective in treatment of chronic vesicular dyshidrotic hand eczema. Acta Derm Venereol 1998; 78: 318-9.
5. Odia S, Vocks E, Rakoski J, Ring J. Successful treatment of dyshidrotic hand eczema using tap water iontophoresis with pulsed direct current. Acta Derm Venereol 1996; 76: 472-4.
6. Kerscher M, Dirschka T, Volkenandt M. Treatment of localised scleroderma by UVA1 phototherapy. Lancet 1995; 346: 1166.
7. Krutmann J, Czech W, Diepgen T et al. High-dose UVA1 therapy in the treatment of patients with atopic dermatitis. J Am Acad Dermatol 1992; 26: 225-30.
8. Zane C, Leali C, Airo P et al. 'High-dose' UVA1 therapy of widespread plaque-type, nodular, and erythrodermic mycosis fungoides. J Am Acad Dermatol 2001; 44: 629-33.
9. Morita A, Werfel T, Stege H et al. Evidence that singlet oxygen-induced human T helper cell apoptosis is the basic mechanism of ultraviolet-A radiation phototherapy. J Exp Med 1997; 186: 1763-8.
10. Abeck D, Schmidt T, Fesq H et al. Long-term efficacy of medium-dose UVA1 phototherapy in atopic dermatitis. J Am Acad Dermatol 2000; 42: 254-7.
11. Vowels BR, Yoo EK, Gasparro FP. Kinetic analysis of apoptosis induction in human cell lines by UVA and 8-MOP. Photochem Photobiol 1996; 63: 572-6.
12. Grewe M, Gyufko K, Krutmann J. Interleukin-10 production by cultured human keratinocytes: regulation by ultraviolet B and ultraviolet A1 radiation. J Invest Dermatol 1995; 104: 3-6.
13. Ley RD, Fourtanier A. UVAI-induced edema and pyrimidine dimers in murine skin. Photochem Photobiol 2000; 72: 485-7.
14. Burren R, Scaletta C, Frenk E et al. Sunlight and carcinogenesis: expression of p53 and pyrimidine dimers in human skin following UVA I, UVA I + II and solar simulating radiations. Int J Cancer 1998; 76: 201-6.
15. Seite S, Moyal D, Verdier MP et al. Accumulated p53 protein and UVA protection level of sunscreens. Photodermatol Photoimmunol Photomed 2000; 16: 3-9.
16. Lavker R, Kaidbey K. The spectral dependence for UVA-induced cumulative damage in human skin. J Invest Dermatol 1997; 108: 17-21.